ODTC
Price:
$22005
Market Cap:
$24.14B
Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York.
Industry
Biotechnology
IPO Date
2017-12-07
Stock Exchange
OTC
Ticker
ODTC
According to Odonate Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 7.01%. This represents a change of -1.30% compared to the average of 7.10% of the last 4 quarters.
The mean historical ROE of Odonate Therapeutics, Inc. over the last ten years is -65.95%. The current 7.01% ROE has changed -110.63% with respect to the historical average. Over the past ten years (40 quarters), ODTC's ROE was at its highest in in the September 2022 quarter at 40.84%. The ROE was at its lowest in in the December 2016 quarter at -85.24%.
Average
-65.95%
Median
-71.74%
Minimum
-142.34%
Maximum
42.58%
Discovering the peaks and valleys of Odonate Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 329.38%
Maximum Annual ROE = 42.58%
Minimum Annual Increase = -136.94%
Minimum Annual ROE = -142.34%
| Year | ROE | Change |
|---|---|---|
| 2023 | 6.77% | -84.09% |
| 2022 | 42.58% | -136.94% |
| 2021 | -115.27% | 24.21% |
| 2020 | -92.81% | 34.70% |
| 2019 | -68.90% | -3.96% |
| 2018 | -71.74% | 329.38% |
| 2017 | -16.71% | -87.64% |
| 2016 | -135.13% | -5.07% |
The current ROE of Odonate Therapeutics, Inc. (ODTC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-21.97%
5-year avg
-45.52%
10-year avg
-65.95%
Odonate Therapeutics, Inc.’s ROE is less than JD Health International Inc. (8.34%), less than Eisai Co., Ltd. (5.81%), greater than TuHURA Biosciences, Inc. (-393.18%), less than Generex Biotechnology Corporation (216.76%), greater than IMV Inc. (-508.58%), greater than Sorrento Therapeutics, Inc. (-1904.94%), less than Immune Therapeutics, Inc. (110.65%), less than Humanigen, Inc. (0%), less than Gelesis Holdings, Inc. (31.43%), less than TRACON Pharmaceuticals, Inc. (90.15%),
| Company | ROE | Market cap |
|---|---|---|
| 8.34% | $29.07B | |
| 5.81% | $17.64B | |
| -393.18% | $100.77M | |
| 216.76% | $0 | |
| -508.58% | $117.00 | |
| -1904.94% | $16.54M | |
| 110.65% | $7.78M | |
| 0% | $23.82K | |
| 31.43% | $7.33K | |
| 90.15% | $109.72K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Odonate Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Odonate Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Odonate Therapeutics, Inc.'s ROE?
How is the ROE calculated for Odonate Therapeutics, Inc. (ODTC)?
What is the highest ROE for Odonate Therapeutics, Inc. (ODTC)?
What is the 3-year average ROE for Odonate Therapeutics, Inc. (ODTC)?
What is the 5-year average ROE for Odonate Therapeutics, Inc. (ODTC)?
How does the current ROE for Odonate Therapeutics, Inc. (ODTC) compare to its historical average?